What is Iovance Biotherapeutics, Inc.'s capex?

Iovance Biotherapeutics, Inc. (IOVA) reported capex of $6.61M in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s capex changed year-over-year?

Iovance Biotherapeutics, Inc.'s capex increased by 6.4% year-over-year, from $6.21M to $6.61M.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s capex?

Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s capex has grown at a -2.6% compound annual growth rate (CAGR), from $37.57M to $33.84M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Iovance Biotherapeutics, Inc. IOVA CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

Gilead SciencesGILD

$117M+12.5%

ImmunomeIMNM

$3M-18.1%

Nuvation BioNUVB

$48K-33.3%

ImmunityBio, Inc.IBRX

$1.78M+58.4%

Immunovant, Inc.IMVT

$8K-96.0%

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.98B+32.4%

Enterprise value$1.83B+33.2%

P/S6.9×-0.1×

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s capex?: Iovance Biotherapeutics, Inc. (IOVA) reported capex of $6.61M in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s capex changed year-over-year?: Iovance Biotherapeutics, Inc.'s capex increased by 6.4% year-over-year, from $6.21M to $6.61M.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s capex?: Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s capex has grown at a -2.6% compound annual growth rate (CAGR), from $37.57M to $33.84M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.